Success: HCV cures - this project will implement a HCV treatment program that is focused on achieving a high cure rate

The Substance Abuse and Mental Health Services Administration awarded Families Against Narcotics, Inc. (doing business as Face Addiction Now) $8.815 million under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) on September 30, 2025.

The recipient will implement an HCV treatment program targeting individuals who are HCV positive, homeless, and have serious mental illness and/or substance use disorders. Deliverables include evidence-based HCV treatment to cure a minimum of 65 persons in grant year one and 105 persons in grant year two; HCV testing for a minimum of 250 persons in grant year two; wraparound case management to a minimum of 210 persons with comprehensive service plans; and identification and engagement strategies to achieve a minimum 12.5% positivity rate among those tested. The project anticipates serving approximately 300 clients in year one and over 1,300 clients across the three-year period.

The period of performance runs from September 30, 2025 through September 29, 2027. Place of performance is Clinton Township, Michigan.

The population to be served are individuals who are HCV positive and who are homeless and have serious mental illness and/or a substance use disorder. Project goals include: goal 1: cure persons who have HCV by providing evidence-based treatments. Objective: by the end of grant year 1, cure a minimum of 65 persons who are enrolled in the project from HCV, and a minimum of 105 persons in grant year 2. Goal 2: test persons who are at high risk for HCV. Objective: in grant year 2, demonstrate that HCV testing was provided to a minimum of 250 persons. Goal 3: engage effective ways of promoting the completion of HCV treatment. Objective: in grant year 2, demonstrate that a minimum of 105 persons complete the samhsa defined minimum course of HCV treatment. Goal 4: utilize effective means for the identification of potential HCV patients. Objective: in grant year 2, demonstrate that 12.5% or more of persons tested for HCV actually test positive for HCV. Goal 5: promote effective means for the reduction of HCV reinfection. Objective: in grant year 2, demonstrate that wraparound case management was provided to a minimum of 210 persons, as evidenced by the completion of a comprehensive service plan. We anticipate serving 300 clients in year 1, and over 1,300 clients over the 3-years grant.